| Medication | Mechanism | Dosing | Key Points |
| Naltrexone (oral/IM) | μ-opioid antagonist → reduces reward/craving | 50 mg/day PO or 380 mg IM q4wk | Start after detox; avoid opioids; LFT monitoring |
| Acamprosate | Modulates glutamate/GABA → reduces protracted withdrawal | 666 mg TID | Renal dosing; start post-detox; no abuse potential |
| Disulfiram | ALDH inhibitor → acetaldehyde accumulation if alcohol consumed | 250 mg/day | Requires high motivation; avoid all alcohol (sauces, mouthwash) |
4. Mutual Support Groups
AA (12-step), SMART Recovery (CBT-based), LifeRing, Women for Sobriety, Refuge Recovery. Free, widely available, improve outcomes when combined with professional treatment.
5. Levels of Care (ASAM Criteria)
- Level 0.5: Early intervention
- Level 1: Outpatient (<9 hrs/wk)
- Level 2.1: Intensive Outpatient (IOP) 9–19 hrs/wk
- Level 2.5: Partial Hospitalization (PHP) ≥20 hrs/wk
- Level 3: Residential/Inpatient (3.1–3.7)
- Level 4: Medically Managed Intensive Inpatient
Relapse Is Part of the Course
Chronic relapsing disorder. Treatment reduces frequency/severity. Long-term follow-up, recovery coaching, and addressing comorbidities (depression, anxiety, trauma) are essential.
Drug Addiction - Related Articles